Prof. Charles Agyemang’s research is focused on ethnic inequalities in health with a major focus on cardiovascular diseases; and NCDs in low- and middle-income countries. In particular, he focuses on gaining insights into how migration and the contexts in which migrants and ethnic minority groups live and work shape their health, with the ultimate aim of translating his research findings to targeted intervention programs and clinical practices that are most appropriate for these populations. Lately, he has focused his attention on the disproportionate impact of COVID-19 on racial and ethnic minorities in places like the UK, the US, and the Netherlands.

He is a Professor of Global Migration, Ethnicity and Health, and Principal Investigator at Amsterdam University Medical Centres, University of Amsterdam (AMC-UvA). He is also currently the Vice President of the Migrant Health section of the European Public health Association; Scientific Chair of the Global Society of Migration, Ethnicity, Race & Health; and a fellow of the prestigious European Research Council (ERC) under the Consolidation Award program. He is the PI of the RODAM study (www.rod-am.EU) and has published extensively and edited several books. He is a member of the WHO task force on NCDs in Migrants and was also a member and a rapporteur of the Planning Committee for WHO Global Consultation on Migrant Health. He is a member of the Lancet Racial Equality Advisory Board and the European Hypertension Society Workgroup on Hypertension & Cardiovascular Risk in Low Resource Settings. Prof. Agyemang serves as a member of several scientific advisory boards.